Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


SpikeTidesTM peptides – light – heavy – quantified. The most economic source for quantified heavy peptides!

Product Image
Product Description

JPT’s SpikeTidesTM are customized, small scale, proteotypic peptides. They are produced light or isotopically labeled and /or absolutely quantified. Libraries of thousands of peptides at economic pricing become available for the first time due to JPT’s proprietary synthesis and quantification technology.

Applications for SpikeTidesTMDSC_8236_klein.gif
- Identification & optimization of proteotypic peptides
- Development of SRM/MRM assays
- Absolute and relative quantification of protein expression levels
- Biomarker discovery and validation
- Clinical monitoring of therapeutic invention and disease status

Benefits of SpikeTidesTM
- Most economic source for proteotypic peptides
- Compatible with current proteomic workflows
- Unmatched turnaround times (10 000 peptides within 2 weeks!)
- Delivery in ready-to-use microtiter plates
- JPT’s quantification method is as robust and much more cost effective than AAA

Specifications of your SpikeTidesTM

SpikeTidesTM
Small scale, unpurified proteotypic peptides
SpikeTidesTM_L
SpikeTidesTM with heavily labeled C-terminal lysine or arginine (Arg M +10 or Lys M +8)
SpikeTidesTM_TQ
SpikeTidesTM absolutely quantified using our patented Quanti-tag.
SpikeTidesTM_TQL
SpikeTidesTM with heavily labeled C-terminal lysine or arginine (Arg M +10 or Lys M + 8) and absolutely quantified using our patented Quanti-tag.


SpikeTidesTM  with Post-Translational Modifications
- Alkylation of cysteines (corresponding to iodoactamide method)
- Phosphorylation, glycosylation, methylation and other upon request

QC/QA for all SpikeTidesTM
ISO 9001:2008 Certification & GCLP Compliance

Selected References

•    Glatter et al.: "Large-Scale Quantitative Assessment of Different In-Solution Protein Digestion Protocols Reveals Superior Cleavage Efficiency of Tandem Lys-C/Trypsin Proteolysis over Trypsin Digestion" Journal of Proteome Research (2012)
•    Sabido et al.: "Targeted Proteomics of the Eicosanoid Biosynthetic Pathway Completes an Integrated Genomics-Proteomics-Metabolomics Picture of Cellular Metabolism" Mol Cell Proteomics (2012)
•    Hewel et al.: “Synthetic peptide arrays for pathway-level protein monitoring by LC-MS/MS.” Mol Cell Proteomics (2010)
•    Picotti et al.: "Full Dynamic Range Proteome. Analysis of S. cerevisiae by Targeted Proteomics" Cell (2009)

DSC_8305_klein.gif

Testimonials
"My unit at the Banting and Best Department of Medical Research, University of Toronto Centre for Cellular and Biomolecular Research (CCBR) works on the systematic identification and quantification of proteins and protein complexes on a global level. In addition we have started to perform targeted proteomics to study protein regulation within pathways, e.g. signaling pathways during stem cell fate decision. For this we used JPT's various SpikeTides™ peptide products to build LC-MRM assays in a fast and cost efficient manner. More recently we also found new ways of using low cost SpikeTides™ as quantitative peptide standards in order to quantify protein targets more accurately. We are currently in the process of validating this technology for the accurate quantification of various predicted microRNA targets."
Prof. Andrew Emili (Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Canada)

“We at the ETH successfully apply JPT’s unpurified isotope- and non-labeled peptide libraries for proteome-wide SRM assays allowing us to identify and quantify proteins spanning a broad range of abundances, including proteins not previously detectable. With the ability to produce large numbers of affordable small scale proteotypic peptides we envision for the first time the development of assays for the quantitative analysis for any protein of interest and covering of whole proteomes.”
Paola Picotti, PhD (Institute of Molecular Systems Biology, ETH Zürich, Switzerland)

Product SpikeTidesTM peptides – light – heavy – quantified. The most economic source for quantified heavy peptides!
Company JPT Peptide Technologies
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

JPT Peptide Technologies
Volmerstrasse 5, 12489 Berlin, Germany

Tel: +49-30-6392-7878 or 1.888.578.2660 (for USA/Canada)
Fax: +49-30-6392-7888 or 1.888.578.2666 (for USA/Canada)
Email: peptide@jpt.com



Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
Fighting Cancer Through Protein Pathways
Researchers have found a new drug target within a protein production pathway critical to regulating growth and proliferation of cells.
Uncovering Rhinovirus C Structure
Researchers have determined the structure of rhinovirus C. Their findings may aid the development of antiviral therapies and vaccines.
New Centre Offers Ultra-Speed Protein Analysis
UW-Madison researchers to establish development centre for next-gen protein measurement technologies.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Virus Inspired Cell Cargo Ships
Virus-inspired container design may lead to cell cargo ships following construction of ten large, two-component, icosahedral protein complexes.
Protein Reinforces Growth of Damaged Muscles
Biologists have found a protein involved in stem cells that bolsters damaged muscle tissue growth - potential for muscle degeneration treatments.
Structure of Cold Virus Solved
Researchers have identified the structure of an elusive cold virus linked to child asthma and respiratory infections, providing the foundation for treating the virus.
New Protein Model Could Accelerate Drug Development
Stony Brook-led international research team creates ultra-fast approach to model protein interactions.
Scroll Up
Scroll Down

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!